CN220159276U - GammA-Aminobutyric acid optimal control device - Google Patents
GammA-Aminobutyric acid optimal control device Download PDFInfo
- Publication number
- CN220159276U CN220159276U CN202321402933.4U CN202321402933U CN220159276U CN 220159276 U CN220159276 U CN 220159276U CN 202321402933 U CN202321402933 U CN 202321402933U CN 220159276 U CN220159276 U CN 220159276U
- Authority
- CN
- China
- Prior art keywords
- carbon filter
- purification
- box
- active carbon
- gamma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 title claims abstract description 106
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 title claims abstract description 53
- 229960003692 gamma aminobutyric acid Drugs 0.000 title claims abstract description 53
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 109
- 238000000746 purification Methods 0.000 claims abstract description 75
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims abstract description 41
- 239000002253 acid Substances 0.000 claims abstract description 41
- 239000003729 cation exchange resin Substances 0.000 claims abstract description 41
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 39
- 230000008676 import Effects 0.000 claims abstract description 5
- 239000012528 membrane Substances 0.000 claims description 30
- 238000000108 ultra-filtration Methods 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 24
- 238000004891 communication Methods 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 238000005457 optimization Methods 0.000 abstract description 9
- 238000000034 method Methods 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 description 19
- 239000003814 drug Substances 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000012535 impurity Substances 0.000 description 8
- 239000000084 colloidal system Substances 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 238000001914 filtration Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
The utility model provides an optimized gammA-Aminobutyric acid control device, which relates to the technical field of gammA-Aminobutyric acid production and comprises a box body active carbon filter box, wherein the bottom of the active carbon filter box is provided with a purification box communicated with the active carbon filter box, the bottom of the active carbon filter box is provided with an export hole, the top of the purification box is provided with an import hole at the corresponding position of the export hole at the bottom of the active carbon filter box, a strong acid type cation exchange resin device communicated with the export hole at the bottom of the active carbon filter box and the import hole at the top of the purification box is detachably arranged between the export hole at the bottom of the active carbon filter box and the import hole at the top of the purification box, and the bottom of the inner side of the purification box is provided with a second active carbon filter plate. According to the utility model, the strong acid type cation exchange resin device is detachably arranged between the active carbon filter box and the purification box, so that a user can rapidly detach the strong acid type cation exchange resin device from the active carbon filter box and the purification box in the gammA-Aminobutyric acid purification optimization process, and the strong acid type cation exchange resin tube is cleaned and replaced.
Description
Technical Field
The utility model relates to the technical field of gammA-Aminobutyric acid production, in particular to an optimized control device for gammA-Aminobutyric acid.
Background
GammA-Aminobutyric acid is an important central nervous system inhibitory neurotransmitter, which has good water solubility and thermal stability. However, the separation and extraction devices of the gammA-Aminobutyric acid are few, and in the use process, the traditional purification device for producing the gammA-Aminobutyric acid is inconvenient for workers to carry out multistage purification on the gammA-Aminobutyric acid in actual use, so that the purification efficiency is influenced, and the disassembly and assembly of the workers are inconvenient, so that the cleaning work of the workers on the purification device is influenced.
The utility model patent with the publication number of CN214361090U discloses a purification device for producing gammA-Aminobutyric acid, wherein pretreatment components are fixedly arranged on two sides of the top of a purification box, each pretreatment component comprises an active carbon filter pipe and a strong acid type cation exchange resin pipe, gammA-Aminobutyric acid materials are filtered by the active carbon filter pipe and then softened by the strong acid type cation exchange resin pipe, the softened gammA-Aminobutyric acid materials are led into the purification box and are subjected to dosing operation by a dosing groove outside the purification box, a motor is used for driving a first stirring paddle and a second stirring paddle to rotate so as to mix the gammA-Aminobutyric acid with medicines, and finally, the gammA-Aminobutyric acid is filtered and purified by an ultrafiltration membrane arranged at the bottom of the purification box, so that the gammA-Aminobutyric acid is subjected to multistage purification, and the purification efficiency is improved; through setting up the material subassembly of arranging in the bottom activity of purifying box, can utilize ring flange and binding bolt to cooperate and use and install the material subassembly of arranging, this structure dismouting is simple, and the staff of being convenient for clear up work.
However, in the process of purifying and optimizing the gammA-Aminobutyric acid, the strong acid type cation exchange resin tube needs to be frequently cleaned and replaced, and the active carbon filter tube and the strong acid type cation exchange resin tube are fixedly connected, so that the strong acid type cation exchange resin tube is inconvenient to clean and replace; in addition, after the gammA-Aminobutyric acid and the medicine are mixed and reacted, larger particle impurities and colloids can be formed, and when the larger particle impurities and colloids are filtered through the ultrafiltration membrane at the bottom of the purification box, the larger particle impurities and colloids can be attached to the surface of the ultrafiltration membrane, so that the purification optimization time of the purification device is influenced, and the replacement times of the ultrafiltration membrane are increased.
Disclosure of Invention
In order to solve the technical problems that a strong acid type cation exchange resin tube is not easy to clean and replace and larger particle impurities and colloids formed after mixing reaction of gammA-Aminobutyric acid and medicines in the prior art can be attached to the surface of an ultrafiltration membrane during filtration, so that the purification optimization time of a purification device is influenced and the replacement frequency of the ultrafiltration membrane is increased, the utility model provides the gammA-Aminobutyric acid optimization control device;
the utility model provides a gammA-Aminobutyric acid optimal control device which adopts the following technical scheme:
the utility model provides a gammA-Aminobutyric acid optimizing control device, includes the active carbon filter tank, active carbon filter tank inside below is provided with first active carbon filter, active carbon filter tank top is provided with the charge door, active carbon filter tank bottom is provided with the purification case with active carbon filter tank intercommunication, be provided with the dosing tube of input reaction medicament on the purification case outer wall, still be provided with the motor on the purification case outer wall, purification incasement portion is provided with the stirring part who is connected with the motor, purification case bottom has the delivery outlet, can dismantle on this delivery outlet and be provided with the milipore filter device, a serial communication port, active carbon filter tank bottom has the leading-out hole, purification case top and active carbon filter tank bottom leading-out hole relevant position are provided with the import hole, can dismantle between active carbon filter tank bottom leading-out hole and the purification case top leading-in hole and be provided with the strong acid type cation exchange resin device with its intercommunication, be provided with the second active carbon filter in purification case inboard bottom.
Further, the strong acid type cation exchange resin device comprises a strong acid type cation exchange resin tube and two fixing rings, wherein the two fixing rings are symmetrically arranged, a mounting through hole is formed in the center of each fixing ring, the strong acid type cation exchange resin tube is inserted into the center hole of each fixing ring, the two fixing rings are respectively arranged at two ends of the strong acid type cation exchange resin tube, a sliding seat is correspondingly arranged on the bottom surface of the activated carbon filter box and the top surface of the purification box, a sliding table is arranged on each fixing ring, and the fixing rings are arranged between the activated carbon filter box and the purification box in a sliding mode.
Further, the stirring part connected with the motor inside the purifying box comprises stirring rods connected with the output shaft of the motor, and a plurality of stirring arms with centers protruding outwards are arranged on the stirring rods.
Further, the ultrafiltration membrane device comprises a discharge seat and an ultrafiltration membrane, wherein the discharge seat is of a hollow structure with an upper opening and a lower opening, the opening at the top of the discharge seat extends to the periphery and is provided with a groove, the ultrafiltration membrane which seals the opening at the top of the discharge seat is arranged in the groove, a fixed table is arranged around the groove at the top of the discharge seat and is fixed on an output port at the bottom of the purification box through bolts, and therefore the ultrafiltration membrane device is detachably arranged on the output port at the bottom of the purification box.
Further, a plurality of support rods are arranged at the bottom of the activated carbon filter box, one end of each support rod is fixedly connected with the activated carbon filter box, and the other end of each support rod is fixedly connected with the purification box, so that the activated carbon filter box is fixed on the purification box.
Further, a bracket for supporting the purifying box upwards is arranged at the bottom of the purifying box.
In summary, the beneficial effects of the utility model are as follows:
1. according to the utility model, the strong acid type cation exchange resin device is detachably arranged between the active carbon filter box and the purification box, so that a user can rapidly detach the strong acid type cation exchange resin device from the active carbon filter box and the purification box in the gammA-Aminobutyric acid purification optimization process, and the strong acid type cation exchange resin tube is cleaned and replaced.
2. According to the utility model, the second activated carbon filter plate is arranged at the bottom of the inner side of the purification box, and larger particle impurities and colloids formed after the mixed reaction of the gammA-Aminobutyric acid and the medicine can be filtered and adsorbed through the second activated carbon filter plate, so that the number of times of replacing an ultrafiltration membrane at the bottom of the purification box is reduced, the filtration time of the ultrafiltration membrane is shortened, and the purification and optimization time of the gammA-Aminobutyric acid by the optimization control device is shortened.
Drawings
FIG. 1 is a schematic perspective view of the present utility model;
FIG. 2 is a schematic front view of the present utility model;
FIG. 3 is a schematic top view of the present utility model;
FIG. 4 is a cross-sectional view taken along the line A-A in FIG. 3 in accordance with the present utility model;
FIG. 5 is a schematic diagram showing the structure of the strong acid type cation exchange resin apparatus 2 of FIG. 2 according to the present utility model.
The following figures are shown: 1-an active carbon filter box; 2-strong acid type cation exchange resin device; 3-a purifying box; 4-an ultrafiltration membrane device; 5-a second activated carbon filter plate; 6-a motor; 101-a charging port; 102-supporting rods; 103-a first activated carbon filter plate; 201-strong acid type cation exchange resin tube; 202-a fixed ring; 203-a slide; 301-a dosing tube; 302-a stent; 401-a discharge seat; 402-ultrafiltration membrane; 403-a stationary stage; 601-stirring rod; 602-stirring arms.
Detailed Description
The utility model will be further described with reference to specific examples, illustrative examples and illustrations of which are provided herein to illustrate the utility model, but are not to be construed as limiting the utility model.
Examples: an optimized control device for gammA-Aminobutyric acid as shown in fig. 1, 2, 3, 4 and 5.
As shown in fig. 1, the gammA-Aminobutyric acid optimizing control device comprises an activated carbon filter box 1, a first activated carbon filter plate 103 is arranged below the inner part of the activated carbon filter box 1, a feed inlet 101 is arranged at the top of the activated carbon filter box 1, and a purifying box 3 communicated with the activated carbon filter box 1 is arranged at the bottom of the activated carbon filter box 1. The bottom of the activated carbon filter tank 1 is provided with a leading-out hole, the corresponding positions of the top of the purification tank 3 and the leading-out hole at the bottom of the activated carbon filter tank 1 are provided with leading-in holes, and a strong acid type cation exchange resin device 2 for communicating the leading-out hole at the bottom of the activated carbon filter tank 1 with the leading-in hole at the top of the purification tank 3 is detachably arranged between the leading-out holes. The purifying box 3 has an accommodating space inside, and a bracket 302 for supporting the purifying box 3 upward is provided at the bottom. The chemical adding pipe 301 for adding the reaction chemical is arranged on the outer wall of one side of the purifying box 3, the motor 6 is also arranged on the outer wall of the purifying box 3, the stirring part connected with the motor 6 is arranged inside the purifying box 3, and the chemical and gammA-Aminobutyric acid materials in the purifying box 3 are mixed and stirred by driving the stirring part through the motor 6. An ultrafiltration membrane device 4 for filtering the gammA-Aminobutyric acid material reacted with the medicament is detachably arranged at the bottom outlet of the purification box 3. When the gammA-Aminobutyric acid purifying device is used, gammA-Aminobutyric acid materials to be optimized are placed into an activated carbon filter box 1 through a charging port 101, larger particles in the gammA-Aminobutyric acid materials are adsorbed and filtered through a first activated carbon filter plate 103 at the bottom of the activated carbon filter box 1, the filtered gammA-Aminobutyric acid materials are softened through a strong acid type cation exchange resin device 2 at the bottom of the activated carbon filter box 1, the softened gammA-Aminobutyric acid materials enter an accommodating space of the purifying box 3 through an introducing hole at the top of the purifying box 3, a medicament is put into the purifying box 3 through a medicament adding pipe 301, and a motor 6 drives a stirring part to stir the medicament in the purifying box 3 and the softened gammA-Aminobutyric acid materials, so that the medicament can react with the softened gammA-Aminobutyric acid materials quickly, and the reacted gammA-Aminobutyric acid materials are further purified and optimized through an ultrafiltration membrane device 4.
As shown in fig. 2, a plurality of support rods 102 are provided at the bottom of the activated carbon filter tank 1, one end of each support rod 102 is fixedly connected with the activated carbon filter tank 1, and the other end is fixedly connected with the purification tank 3, so that the activated carbon filter tank 1 is fixed on the purification tank 3.
The specific structure of the strong acid type cation exchange resin device 2 is shown in fig. 5, and the strong acid type cation exchange resin device comprises two strong acid type cation exchange resin tubes 201 and two fixing rings 202, wherein the fixing rings 202 are symmetrically arranged, the center positions of the fixing rings 202 are provided with mounting through holes, the strong acid type cation exchange resin tubes 201 are inserted into the center holes of the fixing rings 202, the two fixing rings 202 are respectively arranged at two ends of the strong acid type cation exchange resin tubes 201, sliding seats 203 are correspondingly arranged on the bottom surface of the activated carbon filter box 1 and the top surface of the purification box 3, sliding tables are arranged on the fixing rings 202, and the fixing rings 202 are arranged between the activated carbon filter box 1 and the purification box 3 in a sliding mode. When the strong acid type cation exchange resin tube 201 is used, the strong acid type cation exchange resin tube 201 needs to be frequently cleaned or replaced, the existing activated carbon filter box 1 is fixedly connected with the strong acid type cation exchange resin device 2, and the strong acid type cation exchange resin tube 201 in the strong acid type cation exchange resin device 2 is inconvenient to clean or replace singly.
The specific structure of the stirring component connected with the motor 6 inside the purifying box 3 is shown in fig. 4, the stirring component comprises stirring rods 601 connected with the output shaft of the motor 6, and a plurality of stirring arms 602 with centers protruding outwards are arranged on the stirring rods 601. When the medicament and the gammA-Aminobutyric acid material are stirred, the stirring arm 602 protruding outwards enables transverse vortex flow to be generated inside the purifying box 3, and the medicament and the gammA-Aminobutyric acid material at the bottom of the purifying box 3 can rotate upwards along with the vortex flow, so that more uniform reaction of the medicament and the gammA-Aminobutyric acid material in the purifying box 3 is achieved.
As shown in fig. 3, the ultrafiltration membrane device 4 comprises a discharge seat 401 and an ultrafiltration membrane 402, the discharge seat 401 is of a hollow structure with upper and lower openings, the opening at the top of the discharge seat 401 extends to the periphery and is provided with a groove, the ultrafiltration membrane 402 for sealing the opening at the top of the discharge seat 401 is arranged in the groove, and the purification and optimization of gammA-Aminobutyric acid materials after reaction with the medicament are carried out through the ultrafiltration membrane 402. A fixing table 403 is arranged around the groove at the top of the discharging seat 401, and the fixing table 403 is fixed on the bottom outlet of the purifying box 3 through bolts, so that the ultrafiltration membrane device 4 can be detachably arranged on the bottom outlet of the purifying box 3. When the ultrafiltration membrane device is used, the ultrafiltration membrane 402 in the groove at the top of the discharge seat 401 can be replaced by taking down the bolts fixedly connected with the fixing table 403 and the output port at the bottom of the purifying box 3.
In order to reduce the replacement frequency of the ultrafiltration membrane 402 and accelerate the optimization speed of the purification of the gammA-Aminobutyric acid material, as shown in fig. 4, a second activated carbon filter plate 5 is arranged at the bottom of the inner side of the purification box 3, impurities such as larger particles and colloid formed in the gammA-Aminobutyric acid material after the reaction with the medicament are filtered out through the second activated carbon filter plate 5, and then the impurities are further filtered through the ultrafiltration membrane 402, so that the replacement frequency of the ultrafiltration membrane 402 is reduced.
According to the utility model, the strong acid type cation exchange resin device 2 is detachably arranged between the active carbon filter box 1 and the purification box 3, so that a user can quickly detach the strong acid type cation exchange resin device from the active carbon filter box 1 and the purification box 3 in the process of purifying and optimizing gammA-Aminobutyric acid, and the strong acid type cation exchange resin tube 201 is cleaned and replaced. Through having set up second active carbon filter 5 in purification case 3 inboard bottom, can carry out filtration and absorption to the great granule impurity and the colloid that form after gammA-Aminobutyric acid and medicine mixed reaction through second active carbon filter 5 to reduce the change number of times of the milipore filter 402 of purification case 3 bottom, accelerated milipore filter 402's filtration time, and then accelerated this optimizing control device and purified optimizing time to gammA-Aminobutyric acid.
The foregoing shows and describes the basic principles and main features of the present utility model and the advantages of the present utility model. Various components mentioned in the present utility model are common in the art, and it should be understood by those skilled in the art that the present utility model is not limited by the above embodiments, and the above embodiments and descriptions are merely illustrative of the principles of the present utility model, and various changes and modifications can be made in the present utility model without departing from the spirit and scope of the utility model, which is defined in the claims. The scope of the utility model is defined by the appended claims and equivalents thereof.
Claims (6)
1. The utility model provides a gammA-Aminobutyric acid optimizing control device, including active carbon filter case (1), active carbon filter case (1) inside below is provided with first active carbon filter board (103), active carbon filter case (1) top is provided with charge door (101), active carbon filter case (1) bottom is provided with purification case (3) with active carbon filter case (1) intercommunication, be provided with on purification case (3) outer wall and throw into reagent add pencil (301), still be provided with motor (6) on purification case (3) outer wall, purification case (3) inside is provided with the stirring part of being connected with motor (6), purification case (3) bottom has the delivery outlet, can dismantle on this delivery outlet and be provided with milipore filter device (4), a serial communication port, purification case (3) top and active carbon filter case (1) bottom export hole relevant position and active carbon filter case (1), can dismantle between purification case (1) bottom export hole and purification case (3) top and import and be provided with strong acid cation exchange resin device (2) with its intercommunication, purification is provided with second active carbon filter board (5) bottom.
2. The gammA-Aminobutyric acid optimal control device according to claim 1, wherein the strong acid type cation exchange resin device (2) comprises a strong acid type cation exchange resin tube (201) and a fixing ring (202), the fixing ring (202) is two mutually symmetrically arranged, a mounting through hole is formed in the center of the fixing ring (202), the strong acid type cation exchange resin tube (201) is inserted into the center hole of the fixing ring (202), the two fixing rings (202) are respectively arranged at two ends of the strong acid type cation exchange resin tube (201), sliding seats (203) are correspondingly arranged on the bottom surface of the activated carbon filter box (1) and the top surface of the purification box (3), sliding tables are arranged on the fixing ring (202), and the fixing ring (202) is arranged between the activated carbon filter box (1) and the purification box (3) in a sliding mode.
3. The gammA-Aminobutyric acid optimizing control device according to claim 1 or 2, wherein the stirring part connected with the motor (6) inside the purifying box (3) comprises stirring rods (601) connected with the output shaft of the motor (6), and a plurality of stirring arms (602) with centers protruding outwards are arranged on the stirring rods (601).
4. A gammA-Aminobutyric acid optimizing control device as claimed in claim 3, wherein the ultrafiltration membrane device (4) comprises a discharge seat (401) and an ultrafiltration membrane (402), the discharge seat (401) is of a hollow structure with upper and lower openings, the top opening of the discharge seat (401) extends to the periphery and is provided with a groove, an ultrafiltration membrane (402) for sealing the top opening of the discharge seat (401) is arranged in the groove, a fixing table (403) is arranged around the groove at the top of the discharge seat (401), and the fixing table (403) is fixed on the bottom outlet of the purification box (3) through bolts, so that the ultrafiltration membrane device (4) is detachably arranged on the bottom outlet of the purification box (3).
5. The gammA-Aminobutyric acid optimal control device according to claim 1, wherein a plurality of support rods (102) are arranged at the bottom of the activated carbon filter box (1), one end of each support rod (102) is fixedly connected with the activated carbon filter box (1), and the other end of each support rod is fixedly connected with the purification box (3), so that the activated carbon filter box (1) is fixed on the purification box (3).
6. The gammA-Aminobutyric acid optimal control device according to claim 5, wherein a bracket (302) for supporting the purification tank (3) upwards is arranged at the bottom of the purification tank (3).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202321402933.4U CN220159276U (en) | 2023-06-05 | 2023-06-05 | GammA-Aminobutyric acid optimal control device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202321402933.4U CN220159276U (en) | 2023-06-05 | 2023-06-05 | GammA-Aminobutyric acid optimal control device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN220159276U true CN220159276U (en) | 2023-12-12 |
Family
ID=89061623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202321402933.4U Active CN220159276U (en) | 2023-06-05 | 2023-06-05 | GammA-Aminobutyric acid optimal control device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN220159276U (en) |
-
2023
- 2023-06-05 CN CN202321402933.4U patent/CN220159276U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN220159276U (en) | GammA-Aminobutyric acid optimal control device | |
| CN112028399A (en) | Energy-saving sewage treatment device | |
| CN214422397U (en) | Multi-stage water purifying device for treating wastewater | |
| CN212418576U (en) | Centrifugal medicinal material dust collector | |
| CN219334165U (en) | Concentration device and concentration system | |
| CN111847685A (en) | Separate filtration type water treatment device | |
| CN215712484U (en) | Multifunctional domestic sewage treatment equipment | |
| CN220887261U (en) | Integral pretreatment device | |
| CN213803314U (en) | Multistage water purifier for biological experiments | |
| CN101503245A (en) | Double-circulating ceramic membrane bioreactor | |
| CN217323757U (en) | K acid wastewater treatment system | |
| CN209715071U (en) | Urea for vehicle integrated production equipment | |
| CN214936575U (en) | Industrial sewage filtering device | |
| CN218281747U (en) | Filter equipment is used in phosphoric acid purification | |
| CN215427531U (en) | Split type pollutant separator | |
| CN218077216U (en) | Purifier for oxygen production system | |
| CN220056570U (en) | Ultrafiltration membrane integrated purification treatment equipment | |
| CN217351233U (en) | Protein separation and purification device | |
| CN219546804U (en) | Density is with denitrification dephosphorization device based on SMBR | |
| CN213388106U (en) | Integrated stainless steel water purifier | |
| CN216549954U (en) | Equipment for separating organic matters and salt in strong brine | |
| CN220328956U (en) | Oxidation tail gas treatment system of phenol acetone device | |
| CN209093315U (en) | A kind of reactor for cyclohexanone | |
| CN216614293U (en) | Industrial wastewater treatment sedimentation tank capable of preventing industrial wastewater from flowing back | |
| CN213202649U (en) | Clear miscellaneous device of energy-concerving and environment-protective of medicine purified water system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |